| Oral rivaroxaban for the treatment of symptomatic pulmonary embolism HR Büller, MH Prins, AWA Lensing, H Decousus, BF Jacobson, E Minar, ... New England journal of medicine 366 (14), 1287-1297, 2012 | 1335 | 2012 |
| Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised … T Enden, Y Haig, NE Kløw, CE Slagsvold, L Sandvik, W Ghanima, ... The Lancet 379 (9810), 31-38, 2012 | 1231 | 2012 |
| Updated international consensus report on the investigation and management of primary immune thrombocytopenia D Provan, DM Arnold, JB Bussel, BH Chong, N Cooper, T Gernsheimer, ... Blood advances 3 (22), 3780-3817, 2019 | 1043 | 2019 |
| Immune thrombocytopenia N Cooper, W Ghanima New England Journal of Medicine 381 (10), 945-955, 2019 | 454 | 2019 |
| Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial Y Haig, T Enden, O Grøtta, NE Kløw, CE Slagsvold, W Ghanima, ... The Lancet Haematology 3 (2), e64-e71, 2016 | 452 | 2016 |
| Primary chronic cold agglutinin disease: a population based clinical study of 86 patients S Berentsen, E Ulvestad, R Langholm, K Beiske, H Hjorth-Hansen, ... Haematologica 91 (4), 460-466, 2006 | 378 | 2006 |
| Persistent symptoms 1.5–6 months after COVID-19 in non-hospitalised subjects: a population-based cohort study K Stavem, W Ghanima, MK Olsen, HM Gilboe, G Einvik Thorax 76 (4), 405-407, 2021 | 369 | 2021 |
| Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients S Berentsen, E Ulvestad, BT Gjertsen, H Hjorth-Hansen, R Langholm, ... Blood 103 (8), 2925-2928, 2004 | 356 | 2004 |
| Thrombopoietin receptor agonists: ten years later W Ghanima, N Cooper, F Rodeghiero, B Godeau, JB Bussel Haematologica 104 (6), 1112, 2019 | 355 | 2019 |
| Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency T Enden, NE Kløw, L Sandvik, CE Slagsvold, W Ghanima, G Hafsahl, ... Journal of Thrombosis and Haemostasis 7 (8), 1268-1275, 2009 | 354 | 2009 |
| How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment W Ghanima, B Godeau, DB Cines, JB Bussel Blood, The Journal of the American Society of Hematology 120 (5), 960-969, 2012 | 327 | 2012 |
| Rituximab as second-line treatment for adult immune thrombocytopenia (the RITP trial): a multicentre, randomised, double-blind, placebo-controlled trial W Ghanima, A Khelif, A Waage, M Michel, GE Tjønnfjord, NB Romdhan, ... The Lancet 385 (9978), 1653-1661, 2015 | 224 | 2015 |
| Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study K Stavem, W Ghanima, MK Olsen, HM Gilboe, G Einvik International journal of environmental research and public health 18 (4), 2030, 2021 | 188 | 2021 |
| Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis-the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial … T Enden, L Sandvik, NE Kløw, G Hafsahl, PA Holme, LO Holmen, ... American heart journal 154 (5), 808-814, 2007 | 158 | 2007 |
| A nationwide registry study to compare bleeding rates in patients with atrial fibrillation being prescribed oral anticoagulants S Halvorsen, W Ghanima, I Fride Tvete, C Hoxmark, P Falck, O Solli, ... European Heart Journal–Cardiovascular Pharmacotherapy 3 (1), 28-36, 2017 | 149 | 2017 |
| Rituximab plus standard of care for treatment of primary immune thrombocytopenia: a systematic review and meta-analysis S Chugh, S Darvish-Kazem, W Lim, MA Crowther, W Ghanima, G Wang, ... The Lancet Haematology 2 (2), e75-e81, 2015 | 147 | 2015 |
| D-dimer level is associated with the extent of pulmonary embolism W Ghanima, M Abdelnoor, LO Holmen, BE Nielssen, S Ross, PM Sandset Thrombosis research 120 (2), 281-288, 2007 | 133 | 2007 |
| Prevalence and risk factors for post-traumatic stress in hospitalized and non-hospitalized COVID-19 patients G Einvik, T Dammen, W Ghanima, T Heir, K Stavem International Journal of Environmental Research and Public Health 18 (4), 2079, 2021 | 125 | 2021 |
| Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up W Ghanima, JT Geyer, CS Lee, L Boiocchi, AA Imahiyerobo, A Orazi, ... Haematologica 99 (5), 937, 2014 | 122 | 2014 |
| Rituximab and three dexamethasone cycles provide responses similar to splenectomy in women and those with immune thrombocytopenia of less than two years duration JB Bussel, CS Lee, C Seery, AA Imahiyerobo, MV Thompson, D Catellier, ... Haematologica 99 (7), 1264, 2014 | 115 | 2014 |